Bioactive Materials,
Journal Year:
2023,
Volume and Issue:
33, P. 483 - 496
Published: Dec. 3, 2023
Limited
by
low
tumor
immunogenicity
and
the
immunosuppressive
microenvironment
(TME),
triple-negative
breast
cancer
(TNBC)
has
been
poorly
responsive
to
immunotherapy
so
far.
Herein,
a
Ca
&
Mn
dual-ion
hybrid
nanostimulator
(CMS)
is
constructed
enhance
anti-tumor
immunity
through
ferroptosis
inducing
innate
awakening,
which
can
serve
as
inducer
immunoadjuvant
for
TNBC
concurrently.
On
one
hand,
glutathione
(GSH)
depletion
reactive
oxygen
species
(ROS)
generation
be
achieved
due
mixed
valence
state
of
in
CMS.
other
an
exotic
Ca2+
supplier,
CMS
causes
mitochondrial
overload,
further
amplifies
oxidative
stress.
Significantly,
cells
undergo
because
inactivation
peroxidase
4
(GPX4)
accumulation
lipid
peroxidation
(LPO).
More
impressively,
act
awaken
alleviating
intra-tumor
hypoxia
Mn2+-induced
activation
STING
signaling
pathway,
promotes
polarization
tumor-associated
macrophages
(TAMs)
dendritic
(DCs)
antigen
presentation
subsequent
infiltration
tumor-specific
cytotoxic
T
lymphocytes
(CTLs)
into
tissues.
Taken
together,
this
work
demonstrates
novel
strategy
simultaneously
awakening
immunity,
offering
new
perspective
effective
TNBC.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: March 8, 2024
Ferroptosis
is
a
non-apoptotic
form
of
regulated
cell
death
characterized
by
the
lethal
accumulation
iron-dependent
membrane-localized
lipid
peroxides.
It
acts
as
an
innate
tumor
suppressor
mechanism
and
participates
in
biological
processes
tumors.
Intriguingly,
mesenchymal
dedifferentiated
cancer
cells,
which
are
usually
resistant
to
apoptosis
traditional
therapies,
exquisitely
vulnerable
ferroptosis,
further
underscoring
its
potential
treatment
approach
for
cancers,
especially
refractory
cancers.
However,
impact
ferroptosis
on
extends
beyond
direct
cytotoxic
effect
cells.
induction
not
only
inhibits
but
also
promotes
development
due
negative
anticancer
immunity.
Thus,
comprehensive
understanding
role
crucial
successful
translation
therapy
from
laboratory
clinical
applications.
In
this
review,
we
provide
overview
recent
advancements
cancer,
covering
molecular
mechanisms,
functions,
regulatory
pathways,
interactions
with
microenvironment.
We
summarize
applications
immunotherapy,
radiotherapy,
systemic
therapy,
well
inhibition
various
conditions.
finally
discuss
markers,
current
challenges
future
directions
cancer.
Journal of Hematology & Oncology,
Journal Year:
2024,
Volume and Issue:
17(1)
Published: June 6, 2024
Abstract
Ferroptosis,
an
iron-dependent
form
of
cell
death
characterized
by
uncontrolled
lipid
peroxidation,
is
governed
molecular
networks
involving
diverse
molecules
and
organelles.
Since
its
recognition
as
a
non-apoptotic
pathway
in
2012,
ferroptosis
has
emerged
crucial
mechanism
numerous
physiological
pathological
contexts,
leading
to
significant
therapeutic
advancements
across
wide
range
diseases.
This
review
summarizes
the
fundamental
mechanisms
regulatory
pathways
underlying
ferroptosis,
including
both
GPX4-dependent
-independent
antioxidant
mechanisms.
Additionally,
we
examine
involvement
various
conditions,
cancer,
neurodegenerative
diseases,
sepsis,
ischemia–reperfusion
injury,
autoimmune
disorders,
metabolic
disorders.
Specifically,
explore
role
response
chemotherapy,
radiotherapy,
immunotherapy,
nanotherapy,
targeted
therapy.
Furthermore,
discuss
pharmacological
strategies
for
modulating
potential
biomarkers
monitoring
this
process.
Lastly,
elucidate
interplay
between
other
forms
regulated
death.
Such
insights
hold
promise
advancing
our
understanding
context
human
health
disease.
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(19), P. 12261 - 12275
Published: April 29, 2024
Cancer
immunotherapy
holds
significant
promise
for
addressing
diverse
malignancies.
Nevertheless,
its
efficacy
remains
constrained
by
the
intricate
tumor
immunosuppressive
microenvironment.
Herein,
a
light-triggered
nanozyme
Fe-TCPP-R848-PEG
(Fe-MOF-RP)
was
designed
remodeling
The
Fe-TCPP-MOFs
were
utilized
not
only
as
core
catalysis
component
against
destruction
but
also
biocompatible
delivery
vector
of
an
immunologic
agonist,
improving
long
circulation
and
enrichment.
Concurrently,
it
catalyzes
decomposition
H2O2
within
tumor,
yielding
oxygen
to
augment
photodynamic
therapy.
induced
ferroptosis,
in
synergy
with
therapy,
prompts
liberation
tumor-associated
antigens
from
cells
inducing
immunogenic
cell
death.
Phototriggered
on-demand
release
R848
agonists
stimulated
maturation
dendritic
reverted
tumor-promoting
M2
phenotypes
into
adoptive
M1
macrophages,
which
further
reshaped
Notably,
effectively
restrains
well-established
tumors,
such
B16F10
melanoma.
Moreover,
demonstrates
distal
tumor-inhibiting
effect
upon
situ
light
treatment.
What
is
more,
lung
metastasis
model,
elicits
robust
immune
memory,
conferring
enduring
protection
rechallenge.
Our
study
presents
straightforward
broadly
applicable
strategy
crafting
nanozymes
potential
thwart
cancer
recurrence
metastasis.
Chemistry of Materials,
Journal Year:
2024,
Volume and Issue:
36(2), P. 815 - 828
Published: Jan. 11, 2024
Cuproptosis
is
a
newly
identified
copper-dependent
cell
death
and
holds
great
promise
for
cancer
therapy.
However,
transporting
enough
copper
into
cells
challenge.
Herein,
an
intelligent
cupreous
nanoplatform
(denoted
as
CuO2-MSN@TA-Cu2+),
consisting
of
in
situ
formation
CuO2
within
mesoporous
silica
nanoparticles
(MSN)
then
deposition
with
tannic
acid
(TA)-Cu2+
complex,
designed
developed
to
realize
on-demand
delivery
cuproptosis-based
combination
CuO2-MSN@TA-Cu2+
exhibits
tumor
microenvironment-triggered
therapeutic
activity,
wherein
the
outer
TA-Cu2+
complex
readily
disassembled
release
Cu2+
liberate
internal
produce
H2O2.
The
overloaded
can
not
only
directly
convert
endogenous
H2O2
self-supplied
highly
toxic
hydroxyl
radicals
chemodynamic
therapy
(CDT)
via
Cu-based
Fenton-like
reaction
but
also
undergo
glutathione-mediated
reduction
Cu+
species
induce
potent
cellular
cuproptosis
enhance
CDT.
experimental
results
indicate
that
produces
remarkable
cytotoxicity
against
significantly
suppresses
growth
by
93.42%
mice-bearing
4T1
breast
tumors.
This
work
provides
new
paradigm
boost
cuproptosis-related
may
inspire
design
advanced
nanoplatforms.
Small,
Journal Year:
2024,
Volume and Issue:
20(25)
Published: Jan. 14, 2024
Abstract
Ferroptosis
is
a
new
form
of
regulated
cell
death
featuring
iron‐dependent
lipid
peroxides
accumulation
to
kill
tumor
cells.
A
growing
body
evidence
has
shown
the
potential
ferroptosis‐based
cancer
therapy
in
eradicating
refractory
malignancies
that
are
resistant
apoptosis‐based
conventional
therapies.
In
recent
years,
studies
have
reported
number
ferroptosis
inducers
can
increase
vulnerability
cells
by
regulating
ferroptosis‐related
signaling
pathways.
Encouraged
rapid
development
ferroptosis‐driven
therapies,
interdisciplinary
fields
combine
ferroptosis,
pharmaceutical
chemistry,
and
nanotechnology
focused.
First,
prerequisites
metabolic
pathways
for
briefly
introduced.
Then,
detail
emerging
designed
boost
ferroptosis‐induced
therapy,
including
metal
complexes,
metal‐based
nanoparticles,
metal‐free
nanoparticles
summarized.
Subsequently,
application
synergistic
strategies
with
apoptosis
other
emphasis
on
use
both
cuproptosis
induce
redox
dysregulation
intracellular
bimetallic
copper/iron
metabolism
disorders
during
treatment
discussed.
Finally,
challenges
associated
clinical
translation
future
directions
potentiating
therapies
highlighted.
Chemical Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 14, 2025
Ferroptosis,
an
iron-dependent
form
of
regulatory
cell
death,
has
garnered
significant
interest
as
a
therapeutic
target
in
cancer
treatment
due
to
its
distinct
characteristics,
including
lipid
peroxide
generation
and
redox
imbalance.
However,
clinical
application
oncology
is
currently
limited
by
issues
such
suboptimal
efficacy
potential
off-target
effects.
The
advent
nanotechnology
provided
new
way
for
overcoming
these
challenges
through
the
development
activatable
magnetic
nanoparticles
(MNPs).
These
innovative
MNPs
are
designed
improve
specificity
ferroptosis
induction.
This
Review
delves
into
chemical
biological
principles
guiding
design
ferroptosis-based
therapies
imaging-guided
therapies.
It
discusses
mechanisms
attributes
ferroptosis,
composition
MNPs,
their
mechanism
action
inducers,
integration
with
advanced
imaging
techniques
monitoring.
Additionally,
we
examine
convergence
other
strategies,
chemodynamic
therapy,
photothermal
photodynamic
sonodynamic
immunotherapy,
within
context
nanomedicine
strategies
utilizing
MNPs.
highlights
multifunctional
surpass
limitations
conventional
treatments,
envisioning
future
drug-resistance-free,
precision
diagnostics
treating
recalcitrant
cancers.
Journal of Nanobiotechnology,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Feb. 28, 2025
Cancer
treatment
is
currently
one
of
the
most
critical
healthcare
issues
globally.
A
well-designed
drug
delivery
system
can
precisely
target
tumor
tissues,
improve
efficacy,
and
reduce
damage
to
normal
tissues.
Stimuli-responsive
systems
(SRDDSs)
have
shown
promising
application
prospects.
Intelligent
nano
responsive
endogenous
stimuli
such
as
weak
acidity,
complex
redox
characteristics,
hypoxia,
active
energy
metabolism,
well
exogenous
like
high
temperature,
light,
pressure,
magnetic
fields
are
increasingly
being
applied
in
chemotherapy,
radiotherapy,
photothermal
therapy,
photodynamic
various
other
anticancer
approaches.
Metal–organic
frameworks
(MOFs)
become
candidate
materials
for
constructing
SRDDSs
due
their
large
surface
area,
tunable
porosity
structure,
ease
synthesis
modification,
good
biocompatibility.
This
paper
reviews
MOF-based
modes
cancer
therapy.
It
summarizes
key
aspects,
including
classification,
synthesis,
modifications,
loading
modes,
stimuli-responsive
mechanisms,
roles
different
modalities.
Furthermore,
we
address
current
challenges
summarize
potential
applications
artificial
intelligence
MOF
synthesis.
Finally,
propose
strategies
enhance
efficacy
safety
SRDDSs,
ultimately
aiming
at
facilitating
clinical
translation.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(20), P. 20445 - 20461
Published: Oct. 6, 2023
Radiotherapy
is
inevitably
accompanied
by
some
degree
of
radiation
resistance,
which
leads
to
local
recurrence
and
even
therapeutic
failure.
To
overcome
this
limitation,
herein,
we
report
the
room-temperature
synthesis
an
iodine-
ferrocene-loaded
covalent
organic
framework
(COF)
nanozyme,
termed
TADI-COF-Fc,
for
enhancement
radiotherapeutic
efficacy
in
treatment
radioresistant
esophageal
cancer.
The
iodine
atoms
on
COF
not
only
exerted
a
direct
effect
radiotherapy,
increasing
its
X-ray
absorption,
but
also
promoted
radiolysis
water,
increased
production
reactive
oxygen
species
(ROS).
In
addition,
ferrocene
surface
decoration
disrupted
redox
homeostasis
levels
hydroxyl
lipid
peroxide
radicals
depleting
intracellular
antioxidants.
Both
vitro
vivo
experiments
substantiated
excellent
response
TADI-COF-Fc.
This
study
demonstrates
potential
COF-based
multinanozymes
as
radiosensitizers
suggests
possible
integration
strategy
combination
oncotherapy.